Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(19):1647-1653; doi:10.1093/jnci/91.19.1647
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kitazono, M.
Right arrow Articles by Akiyama, S.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitazono, M.
Right arrow Articles by Akiyama, S.-i.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 19, 1647-1653, October 6, 1999
© 1999 Oxford University Press

Multidrug Resistance and the Lung Resistance-Related Protein in Human Colon Carcinoma SW-620 Cells

Masaki Kitazono, Tomoyuki Sumizawa, Yuji Takebayashi, Zhe-Sheng Chen, Tatsuhiko Furukawa, Shuichi Nagayama, Ayako Tani, Sonshin Takao, Takashi Aikou, Shin-ichi Akiyama

Affiliations of authors: M. Kitazono, Y. Takebayashi, S. Nagayama (Department of Cancer Chemotherapy, Institute for Cancer Research, and First Department of Surgery, Faculty of Medicine), T. Sumizawa, Z.-S. Chen, T. Furukawa, A. Tani, S. Akiyama (Department of Cancer Chemotherapy, Institute for Cancer Research), S. Takao, T. Aikou (First Department of Surgery, Faculty of Medicine), Kagoshima University, Japan.

Correspondence to: Shin-ichi Akiyama, M.D., Department of Cancer Chemotherapy, Institute for Cancer Research, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima 890-8520, Japan (e-mail: akiyamas{at}khosp2.kufm.kagoshima-u.ac.jp).

BACKGROUND: Lung resistance-related protein (LRP), the major vault protein in humans, is sometimes overexpressed in multidrug-resistant cells. Because cells transfected with the LRP gene did not express the multidrug-resistant phenotype, we investigated whether LRP is involved in multidrug resistance. METHODS: SW-620 cells, a human colon carcinoma cell line, alone or transfected with an expression vector carrying a LRP-specific ribozyme or with an empty vector, were treated with sodium butyrate to induce differentiation. Expression of P-glycoprotein, multidrug resistance protein, and LRP in the cells was examined by northern and western blotting, and the efflux of doxorubicin in the cells or isolated nuclei was examined by fluorescence microscopy. RESULTS: A 2-week treatment with sodium butyrate induced LRP and conferred resistance to doxorubicin, vincristine, etoposide, gramicidin D, and paclitaxel (Taxol) in SW-620 cells. Insertion of either of two LRP-specific ribozymes into SW-620 cells inhibited these activities. Levels of drugs accumulating in the cells were not decreased by sodium butyrate, suggesting that the adenosine triphosphate-binding cassette transporter is not involved in sodium butyrate-induced multidrug resistance. Doxorubicin was mainly located in the nuclei of untreated cells and in the cytoplasm of sodium butyrate-treated cells. Isolated nuclei from untreated cells or sodium butyrate-treated cells incubated with anti-LRP polyclonal antibodies contained more doxorubicin than the nuclei of sodium butyrate-treated cells alone. Efflux of doxorubicin was greater from the nuclei of sodium butyrate-treated cells than the nuclei of untreated cells or of sodium butyrate-treated cells transfected with a LRP-specific ribozyme and was inhibited by an anti-LRP polyclonal antibody. CONCLUSIONS: LRP is involved in resistance to doxorubicin, vincristine, etoposide, paclitaxel, and gramicidin D and has an important role in the transport of doxorubicin from the nucleus to the cytoplasm.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Biol EvolHome page
P. F. Stadler, J. J.-L. Chen, J. Hackermuller, S. Hoffmann, F. Horn, P. Khaitovich, A. K. Kretzschmar, A. Mosig, S. J. Prohaska, X. Qi, et al.
Evolution of Vault RNAs
Mol. Biol. Evol., September 1, 2009; 26(9): 1975 - 1991.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Fujii, A. Kawahara, Y. Basaki, S. Hattori, K. Nakashima, K. Nakano, K. Shirouzu, K. Kohno, T. Yanagawa, H. Yamana, et al.
Expression of HER2 and Estrogen Receptor {alpha} Depends upon Nuclear Localization of Y-Box Binding Protein-1 in Human Breast Cancers
Cancer Res., March 1, 2008; 68(5): 1504 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Herlevsen, G. Oxford, C. R. Owens, M. Conaway, and D. Theodorescu
Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes
Mol. Cancer Ther., June 1, 2007; 6(6): 1804 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. C. B. Gopinath, A. Matsugami, M. Katahira, and P. K. R. Kumar
Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound
Nucleic Acids Res., September 8, 2005; 33(15): 4874 - 4881.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. van Zon, M. H. Mossink, M. Schoester, R. J. Scheper, P. Sonneveld, and E. A. C. Wiemer
Efflux Kinetics and Intracellular Distribution of Daunorubicin Are Not Affected by Major Vault Protein/Lung Resistance-Related Protein (Vault) Expression
Cancer Res., July 15, 2004; 64(14): 4887 - 4892.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. H. Yang, M. H. Ma, R. A. Vescio, and J. R. Berenson
Overcoming Drug Resistance in Multiple Myeloma: The Emergence of Therapeutic Approaches to Induce Apoptosis
J. Clin. Oncol., November 15, 2003; 21(22): 4239 - 4247.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. van Zon, M. H. Mossink, M. Schoester, A. B. Houtsmuller, G. L. Scheffer, R. J. Scheper, P. Sonneveld, and E. A. C. Wiemer
The formation of vault-tubes: a dynamic interaction between vaults and vault PARP
J. Cell Sci., November 1, 2003; 116(21): 4391 - 4400.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Singhal, R. Wiewrodt, L. D. Malden, K. M. Amin, K. Matzie, J. Friedberg, J. C. Kucharczuk, L. A. Litzky, S. W. Johnson, L. R. Kaiser, et al.
Gene Expression Profiling of Malignant Mesothelioma
Clin. Cancer Res., August 1, 2003; 9(8): 3080 - 3097.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Burger, J. A. Foekens, M. P. Look, M. E. Meijer-van Gelder, J. G. M. Klijn, E. A. C. Wiemer, G. Stoter, and K. Nooter
RNA Expression of Breast Cancer Resistance Protein, Lung Resistance-related Protein, Multidrug Resistance-associated Proteins 1 and 2, and Multidrug Resistance Gene 1 in Breast Cancer: Correlation with Chemotherapeutic Response
Clin. Cancer Res., February 1, 2003; 9(2): 827 - 836.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. Wang, T. Furukawa, T. Nitanda, M. Okamoto, Y. Sugimoto, S.-I. Akiyama, and M. Baba
Breast Cancer Resistance Protein (BCRP/ABCG2) Induces Cellular Resistance to HIV-1 Nucleoside Reverse Transcriptase Inhibitors
Mol. Pharmacol., January 1, 2003; 63(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. H. Mossink, A. van Zon, E. Franzel-Luiten, M. Schoester, V. A. Kickhoefer, G. L. Scheffer, R. J. Scheper, P. Sonneveld, and E. A. C. Wiemer
Disruption of the Murine Major Vault Protein (MVP/LRP) Gene Does Not Induce Hypersensitivity to Cytostatics
Cancer Res., December 15, 2002; 62(24): 7298 - 7304.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Raidl, W. Berger, R. Schulte-Hermann, D. Kandioler-Eckersberger, S. Kappel, F. Wrba, M. Micksche, and B. Grasl-Kraupp
Expression of the lung resistance-related protein in human and rat hepatocarcinogenesis
Am J Physiol Gastrointest Liver Physiol, November 1, 2002; 283(5): G1117 - G1124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Yu, N. Fotouhi-Ardakani, L. Wu, M. Maoui, S. Wang, D. Banville, and S.-H. Shen
PTEN Associates with the Vault Particles in HeLa Cells
J. Biol. Chem., October 18, 2002; 277(43): 40247 - 40252.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Toppmeyer, A. D. Seidman, M. Pollak, C. Russell, K. Tkaczuk, S. Verma, B. Overmoyer, V. Garg, E. Ette, M. W. Harding, et al.
Safety and Efficacy of the Multidrug Resistance Inhibitor Incel (Biricodar; VX-710) in Combination with Paclitaxel for Advanced Breast Cancer Refractory to Paclitaxel
Clin. Cancer Res., March 1, 2002; 8(3): 670 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. B. Schroeijers, A. W. Reurs, G. L. Scheffer, A. G. M. Stam, M. C. de Jong, T. Rustemeyer, E. A. C. Wiemer, T. D. de Gruijl, and R. J. Scheper
Up-Regulation of Drug Resistance-Related Vaults During Dendritic Cell Development
J. Immunol., February 15, 2002; 168(4): 1572 - 1578.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Zembutsu, Y. Ohnishi, T. Tsunoda, Y. Furukawa, T. Katagiri, Y. Ueyama, N. Tamaoki, T. Nomura, O. Kitahara, R. Yanagawa, et al.
Genome-wide cDNA Microarray Screening to Correlate Gene Expression Profiles with Sensitivity of 85 Human Cancer Xenografts to Anticancer Drugs
Cancer Res., January 1, 2002; 62(2): 518 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. B. Schroeijers, G. L. Scheffer, A. W. Reurs, A. C.L.M. Pijnenborg, C. Abbondanza, E. A.C. Wiemer, and R. J. Scheper
Detection of the Mr 110,000 Lung Resistance-related Protein LRP/MVP with Monoclonal Antibodies
J. Histochem. Cytochem., November 1, 2001; 49(11): 1379 - 1386.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Ohno, A. Tani, K. Uozumi, S. Hanada, T. Furukawa, S. Akiba, T. Sumizawa, A. Utsunomiya, T. Arima, and S.-i. Akiyama
Expression of functional lung resistance-related protein predicts poor outcome in adult T-cell leukemia
Blood, August 15, 2001; 98(4): 1160 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Okumura, Z.-S. Chen, M. Sakou, T. Sumizawa, T. Furukawa, M. Komatsu, R. Ikeda, H. Suzuki, K. Hirota, T. Aikou, et al.
Reversal of P-Glycoprotein and Multidrug-Resistance Protein-Mediated Drug Resistance in KB Cells by 5-O-Benzoylated Taxinine K
Mol. Pharmacol., April 13, 2001; 58(6): 1563 - 1569.
[Abstract] [Full Text]


Home page
JCBHome page
V. A. Kickhoefer, Y. Liu, L. B. Kong, B. E. Snow, P. L. Stewart, L. Harrington, and L. H. Rome
The Telomerase/Vault-Associated Protein Tep1 Is Required for Vault RNA Stability and Its Association with the Vault Particle
J. Cell Biol., January 8, 2001; 152(1): 157 - 164.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Filipits, U. Jaeger, I. Simonitsch, C. Chizzali-Bonfadin, H. Heinzl, and R. Pirker
Clinical Relevance of the Lung Resistance Protein in Diffuse Large B-Cell Lymphomas
Clin. Cancer Res., September 1, 2000; 6(9): 3417 - 3423.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. B. Schroeijers, A. C. Siva, G. L. Scheffer, M. C. de Jong, S. C. E. Bolick, D. F. Dukers, J. W. Slootstra, R. H. Meloen, E. Wiemer, V. A. Kickhoefer, et al.
The Mr 193,000 Vault Protein Is Up-Regulated in Multidrug-resistant Cancer Cell Lines
Cancer Res., February 1, 2000; 60(4): 1104 - 1110.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
W. S. Dalton and R. J. Scheper
Lung Resistance-Related Protein: Determining Its Role in Multidrug Resistance
J Natl Cancer Inst, October 6, 1999; 91(19): 1604 - 1605.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. G. Stephen, S. Raval-Fernandes, T. Huynh, M. Torres, V. A. Kickhoefer, and L. H. Rome
Assembly of Vault-like Particles in Insect Cells Expressing Only the Major Vault Protein
J. Biol. Chem., June 22, 2001; 276(26): 23217 - 23220.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. van Zon, M. H. Mossink, M. Schoester, G. L. Scheffer, R. J. Scheper, P. Sonneveld, and E. A. C. Wiemer
Multiple Human Vault RNAs. EXPRESSION AND ASSOCIATION WITH THE VAULT COMPLEX
J. Biol. Chem., September 28, 2001; 276(40): 37715 - 37721.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.